Title 21 › Chapter 9— FEDERAL FOOD, DRUG, AND COSMETIC ACT › Subchapter VII— GENERAL AUTHORITY › Part D— Information and Education › § 379k–1
The Secretary must require certain drug, biologic, and device applications to be filed in a digital format the Secretary describes in guidance. For the drug and biologic filings named in the law, that digital-only rule can start no earlier than 24 months after the Secretary issues final guidance that followed public notice and comment. The guidance can also set a timetable for more technical rules and allow waivers or exemptions. The rule does not apply to submissions covered by section 360bbb. For medical device pre-submissions, submissions, their supplements, and some related biologic filings, the Secretary must first require an electronic copy when final guidance is issued. That guidance can set file standards and allow waivers. On a date the Secretary sets in final guidance, those device filings (and appeals) must be submitted only in the specified electronic format. The Secretary had to publish draft guidance by October 1, 2019, and must issue final guidance within 1 year after the public comment period on that draft closes.
Full Legal Text
Food and Drugs, Source: USLM XML via OLRC
Legislative History
Reference
Citation
21 U.S.C. § 379k–1
Title 21, Food and Drugs
Last Updated
Apr 5, 2026
Release point: 119-73not60